MarketPulse

patent portfolio

3 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Glucotrack, Inc.

Glucotrack Narrows Losses, Advances Glucose Monitor Tech Toward FDA Trials

Glucotrack narrowed net losses to $19.4M in 2025 while advancing implantable glucose monitor toward FDA trials in H2 2026.
GCTKFDA approvalclinical trials
GlobeNewswire Inc.GlobeNewswire Inc.··Hop-On, Inc.

Hop-on's Digitalage Launches Stateful Media Infrastructure for Live Streaming

Hop-on subsidiary Digitalage deployed Stateful Media Infrastructure converting live streams into permanent, searchable assets. Three March 2026 milestones achieved; creators retain 70-85% revenue share.
HPNNcreator economypatent portfolio
GlobeNewswire Inc.GlobeNewswire Inc.··Patentvest

Patent Strength, Not Clinical Data, to Drive GLP-1 Market Leadership

Patent strength, not clinical efficacy, will drive GLP-1 market leadership as clinical outcomes converge. Companies with robust IP portfolios may capture disproportionate market share despite comparable results.
PFELLYNVORHHBYAZN+2GLP-1 drugsoral small-molecule